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ABSTRACT
Following the identiﬁcation of two clinical isolates of vancomycin-resistant enterococci (VRE) from
intensive care unit (ICU) patients, a surveillance programme detected that six of eight ICU patients were
colonised by VRE. Standard epidemic control measures were instituted in the ICU. During a 16-month
period, 13 (2.5%) of 509 ICU patients had VRE-positive swabs upon admission, and 43 (8.7%) of 496
VRE-negative patients were colonised by VRE in the ICU. Patients who acquired VRE in the ICU had a
longer ICU stay (p < 0.0001). No other statistically signiﬁcant differences were demonstrated. Two
patients had documented infection (infection ⁄ colonisation index, 3.6%; overall VRE infection frequency,
0.4%), but both recovered and were discharged. VRE colonisation did not increase the mortality rate.
Automated ribotyping identiﬁed three clusters containing, respectively, the ﬁrst 52 Enterococcus faecium
isolates, two Enterococcus faecalis isolates, and two further isolates of E. faecium. Multilocus sequence
typing demonstrated that two E. faecium isolates representative of the two ribotypes belonged to
sequence types 78 and 18, and that these two isolates belonged to the epidemic lineage C1, which
includes isolates with a wide circulation in northern Italy. The outbreak was controlled by continuous
implementation of the infection control programme, and by the opening of a new unit with an improved
structural design and hand-washing facilities.
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INTRODUCTION
Intensive care units (ICUs) are known to be a
focus for the emergence and dissemination of
multiresistant bacteria within and outside the unit
[1], mainly because the most severely-ill patients
can be found in the ICU, and almost all of these
patients will have been exposed to intense anti-
biotic pressure and exogenous bacterial colonisa-
tion. Infection control policies consider that
surveillance programmes and the prevention of
bacterial spread in the ICU are high priority
interventions [2].
Vancomycin-resistant enterococci (VRE) have
been recognised in the USA for many years as
microorganisms capable of causing epidemics in
critically-ill patients [3–5]. Isolation of VRE has
been reported since 1993 in Italy [6,7]. Thus, a
large, multicentre study [7] reported that the
average isolation frequency of vancomycin-resis-
tant Enterococcus faecalis in Italy during 1993–1995
was 1.1%, and that of vancomycin-resistant En-
terococcus faeciumwas 8.5%. A major outbreak was
described in a large tertiary-care hospital in nor-
thern Italy during 1993–1999 [8], and the ﬁrst VRE
outbreak in an Italian ICUwas reported in 1996 [9].
The present report describes an outbreak invol-
ving VRE colonisation and infection in an ICU of
an Italian tertiary university hospital. Before 1998,
there had been no reports of the detection of VRE
in this institution. After 1998, an outbreak was
described in the paediatric haematological unit of
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the hospital [10], with isolated cases diagnosed
and treated in other hospital wards, but VRE had
never been isolated from patients admitted to the
ICU described in the present study. No speciﬁc
surveillance measures were implemented in the
hospital before this new outbreak. Following the
ﬁrst case of VRE infection, and the subsequent
increase in cases of colonisation, an active surveil-
lance programme was implemented, with the
opportunity to collect data regarding transmission
in the unit and the acquisition of VRE frompatients
transferred into the ICU from other wards.
MATERIALS AND METHODS
Setting
The ICU is one of two general ICUs in a tertiary university
hospital (Rianimazione II, IRCCS Policlinico ‘San Matteo’,
Pavia, Italy) with 1000 acute-care beds. The ICU has one large
room with six beds, and two small rooms with two beds each.
Usually, four nurses per shift care for nine patients. There are
c. 400 patients admitted annually to the ICU; more than half
are surgical or trauma patients (Table 1).
Patients
After several months of a severe nursing shortage, when often
there were only three nurses for nine, or even ten, critically-ill
patients, the ﬁrst VRE (index case, 1 April 2001) was isolated
from the purulent urethral secretion of a patient who had
undergone vascular surgery. Following the isolation of VRE
from the cerebrospinal ﬂuid (CSF) of a second patient, initial
rectal swabs from all ICU patients indicated that six of eight
patients were positive for VRE, leading to institution of a
surveillance programme.
Surveillance programme
Rectal swabs were collected from all patients within 24 h of
admission, and on a weekly basis if the patient had a
prolonged ICU stay. This surveillance programme continued
for 16 months. Follow-up samples were also collected at 6, 12
and 18 months after the surveillance period. Different proce-
dures (diagnostic or therapeutic, as well as nursing and
cleaning processes) were considered by a group of internal and
external nurses and physicians. Particular importance was
paid to hand-washing and correct use of gloves and gowns.
Based on the ﬁndings of this investigation, and on the
recommendations of the available guidelines, many processes,
including ward cleaning, nursing procedures and prescribing
of antimicrobial agents, were discussed extensively and
modiﬁed where necessary. One year after the start of the
outbreak, the ICU was moved to a new unit with a better
structural design and better hand-washing facilities.
Microbiological methods
Rectal swabs were resuspended in 1 mL physiological saline
0.85% w ⁄v and vortexed for 1 min; 100 lL was then added to
Enterococcosel broth (Becton Dickinson, Franklin Lakes, NJ,
USA) supplemented with vancomycin 6 mg ⁄L. All cultures
were incubated in air at 35C and examined after 24 and 48 h
for the development of a dark colour resulting from aesculin
hydrolysis. Positive samples were subcultured, followed by
ﬁnal identiﬁcation with the API 20 Strep system (bio-
Me´rieux, Marcy l’Etoile, France) [11]. All isolates were stored
in Bacterial Strain Storage Medium (Bio-Rad, Marnes-la-
Coquette, France). Susceptibility testing for ampicillin, eryth-
romycin, ciproﬂoxacin, rifampicin, glycopeptides and chlo-
ramphenicol was performed using the disk-diffusion method
on Mueller-Hinton agar [12]. Susceptibility to linezolid and
quinupristin-dalfopristin, as well as high-level aminoglycoside
resistance, was determined by Etest [13] for the isolates from
infected patients.
Table 1. Characteristics of patients with and without colonisation by vancomycin-resistant enterococci on admission and
during their stay in the intensive care unit
Total n (%)
Upon admission During ICU stay
Patients not colonised
n (%)
Patients colonised
n (%)
Patients not colonised
n (%)
Patients colonised
n (%)
Admitted from
Emergency department 147 (28.8) 145 (29.2) 2 (15.4) 129 (28) 16 (37.2)
Neurosurgery 136 (26.8) 134 (27) 2 (15.4) 124 (27) 10 (23.3)
Vascular surgery 67 (13.1) 61 (12.3) 6 (46.1) 56 (12) 5 (11.6)
Respiratory medicine 16 (3.2) 16 (3.2) 0 13 (3) 3 (7.0),
Orthopaedic surgery 31 (6.1) 31 (6.2) 0 28 (6) 3 (7.0)
Infectious diseases 10 (1.9) 9 (1.8) 1 (7.7) 8 (2) 1 (2.3)
Paediatrics 11 (2.17) 10 (2) 1 (7.7) 10 (2) 0
Other departments 57 (11.2) 56 (11.3) 1 (7.7) 53 (12) 3 (7.0),
Other hospitals 34 (6.7) 34 (6.8) 0 32 (7) 2 (4.6)
Total 509 496 13 453 43
Patient population
Trauma 146 (28.6) 146 (29.4) 0 11 (25.6) 135
Surgical 196 (38.5) 187 (37.7) 9 (69) 18 (41.9) 169
Medical 167 (32.9) 163 (32.8) 4 (31) 14 (32.6) 149
ICU mortality 116 (22.8) 114 (23) a 2 (15.4) a 108 (23.8) b 6 (13.9) b
Gender (M ⁄ F) 302 ⁄ 207 293 ⁄ 203 9 ⁄ 4 264 ⁄ 189 29 ⁄ 14
Mean age, years (± SD) 54.6 (± 22.6) 54.21 (± 21.99) 64.5 (± 20.77) 53.59 (± 22.51) 60.77 (± 14.04)
Mean ICU stay, days (± SD) 7.6 (± 14.6) 8.06 (± 14.58) c 10.54 (± 18.43) c 6.11 (± 11.81) d 28.63 (± 22.98) d
ICU, intensive care unit.
a, b, c data compared in pairs, no statistically signiﬁcant difference; dp < 0.0001 between the groups analysed.
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Genotypic resistance
Total enterococcal DNA was extracted using standard proce-
dures (lytic agents, extraction with phenol-chloroform and
precipitation with ethanol) and was then ampliﬁed by PCR as
described by Dutka-Malen et al. [14].
Automated ribotyping
Ribotyping was performed for single isolates from colonised
patients and for all isolates from infected patients. A vanco-
mycin-resistant E. faecium, isolated previously in a different
ward of the hospital [10], was used as an internal control. The
automated RiboPrinter microbial characterisation system
(Qualicon, Wilmington, DE, USA) was used to identify and
type isolates as outlined previously [15]. VRE isolates were
typed using EcoRI [16] and a combination of EcoRI and BamHI.
The strain classiﬁcation obtained via the software was adjusted
by visual inspection and manual correction. The reproducibil-
ity of the patterns obtained was evaluated with repeat testing
of 10% of isolates chosen randomly.
Multilocus sequence typing (MLST) and pulsed-ﬁeld gel
electrophoresis (PFGE)
MLST [17,18] was used to analyse the genetic relationship
between two E. faecium isolates with different ribotypes, and
with other strains isolated previously from outbreaks in
different hospitals in the same geographical area [8,19]. These
isolates were also analysed by PFGE as described previously
[19].
Statistical analysis
For comparison of two means, Student’s t-test was used. A chi-
square test was performed to compare mortality (patients who
were VRE-negative upon admission vs. patients who were
VRE-colonised upon admission, and patients who were VRE-
colonised in the ICU vs. patients who remained VRE-negative);
p < 0.05 was considered to be statistically signiﬁcant.
RESULTS
Surveillance cultures and patients
In total, 953 rectal swabs from 509 patients were
analysed. VRE was isolated from 139 (14.5%)
swabs from 56 patients (11%). All the patients
were colonised by E. faecium; colonisation by
E. faecalis was detected in only two cases. The
vanA gene was detected in all isolates. Relevant
data concerning the study population are sum-
marised in Table 1.
Thirteen (2.5%) patients had VRE-positive rec-
tal swabs upon admission; most (46%) had been
transferred from the vascular surgery depart-
ment. In addition, the two colonised patients
admitted from the emergency department
(Table 1) had been discharged only recently from
a surgical department of the hospital. As expec-
ted, none of the trauma patients yielded VRE-
positive swabs upon admission.
Forty-three (8.7%) of the 496 patients who were
VRE-negative on admission were colonised by
VRE during their ICU stay. These patients had
a longer mean ICU stay than non-colonised
patients (28.63 vs. 6.11 days) (Table 1). Of the 56
patients with VRE-positive rectal swabs, eight
died in the ICU, 31 were discharged to other
wards of the same hospital, and ten were dis-
charged to other hospitals or long-term care
facilities. The remaining seven patients who were
colonised during their ICU stay had negative
rectal swabs on discharge from the ICU. Two of
these patients had been treated with linezolid for
VRE infection. ICU mortality was not affected by
VRE colonisation status (Table 1).
TwoVRE infectionswere documented among 56
colonised patients; VRE was isolated from three
different CSF cultures from one patient, and was
isolated from blood samples from the other. The
infection ⁄ colonisation index was 3.6% (infected
patients vs. overall study group, 0.4%). Fig. 1
depicts VRE colonisation in terms of the number
of days during which VRE-positive patients were
present in the ICU during each week.
Susceptibility pattern
All E. faecium isolates were resistant to all the
drugs tested, except for chloramphenicol (all the
isolates were susceptible). The isolates from infec-
ted patients were susceptible to linezolid and
quinupristin-dalfopristin, and did not show high-
level resistance to aminoglycosides. The ﬁrst
E. faecalis isolate was also resistant to all anti-
microbial agents tested, except chloramphenicol,
whereas the second was susceptible to ampicillin,
rifampicin and chloramphenicol.
Molecular typing
Using automated ribotyping with EcoRI, the
isolates were grouped into three clusters. Most
(n = 52) E. faecium isolates were grouped into one
cluster. The other clusters contained two E. faecalis
and two E. faecium isolates, respectively. The
vancomycin-resistant E. faecium isolate obtained
previously from a different ward of the hospital
had a different ribotype (Fig. 2). Results obtained
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with the combination of EcoRI and BamHI yielded
the same clusters as the EcoRI data.
MLST and PFGE were performed on two
E. faecium isolates representative of the two
ribogroup clusters containing this species. The
isolate from the major ribogroup belonged to
MLST sequence type (ST) 78, which is shared by
isolates from outbreaks in other hospitals in cities
of northern Italy (Torino, Verona, Vicenza, Ver-
celli) [8,19]. The E. faecium isolate from the other
cluster belonged to ST18. Both of these E. faecium
isolates had a unique purK1 allele, but only the
ST78 isolate harboured the esp (enterococcal sur-
face protein) gene, which is a putative virulence
factor [20]. PFGE conﬁrmed that the two isolates
were not related (‡ seven bands difference) [21].
The ST78 isolate had a PFGE pattern related to
that of strain SM685 (two bands different), which
is representative of a wide outbreak in northern
Italy during 2000–2003 [19,22].
Follow-up
Results from the follow-up surveillance study are
summarised in Table 2. A large number of colon-
ised patients were admitted to the ICU during
March 2003, perhaps related to a VRE outbreak in
another ward of the hospital at this time. How-
ever, after 12 and 18 months, no patients in the
ICU were colonised by VRE, and all patients with
VRE were admitted from other wards.
DISCUSSION
Although reported frequently in the USA, VRE
outbreaks in ICUs have been reported only rarely
in Italy [9,23]. The outbreak described is not
remarkable for its clinical impact, as the infection
Fig. 1. Colonisation of patients by
vancomycin-resistant enterococci
(VRE) in the intensive care unit
(ICU), expressed as the percentage
of beds occupied by VRE-colonised
patients ⁄week. Each column repre-
sents one ICU-week, with the height
of the column indicating the per-
centage of theoretically possible
bed-days each week occupied by
VRE-colonised patients. The signiﬁ-
cantly longer ICU stay (see Table 1)
of VRE-positive patients causes an
even greater impact than would be
expected from the number of
VRE-positive patients.
EcoRI
M 1 2 3 4 M M1 2 3 4
EcoRI + BamHI
Fig. 2. Examples of the ribotype proﬁles obtained for
isolates of vancomycin-resistant enterococci (modiﬁed
from images generated by the automated Riboprinter).
Lanes: 1, Enterococcus faeciummajor ribogroup (52 isolates);
2, E. faecium minor ribogroup (two isolates); 3, Enterococus
faecalis ribogroup (two isolates); 4, internal control (an
E. faecium isolate from a previous outbreak in the same
hospital [10].
Table 2. Long-term follow-up surveillance results for VRE
March 2003
(6 months after
outbreak)
September 2003
(12 months after
outbreak)
March 2004
(18 months after
outbreak)
Number of swabs 70 58 45
Number of patients 45 34 35
Positive cultures 16 0 2
Patients VRE+ on admission 7 0 2
Patients VRE+ in ICU 2 0 0
ICU, intensive care unit; VRE, vancomycin-resistant enterococci.
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rate was low (two cases of infection among 56
VRE-colonised patients, both of whom were
treated successfully with linezolid or quinupris-
tin-dalfopristin). However, the long period of
active surveillance and molecular analysis
enabled detailed study of the outbreak. Upon
admission, 2.5% of patients had positive VRE
rectal swabs; most were admitted from vascular
surgery, but colonised patients also came from
other wards, indicating widespread dissemin-
ation of VRE throughout the hospital. In the
present study, the only important feature of
colonised patients was a long ICU stay; VRE
colonisation per se did not increase mortality. A
long ICU stay, the contemporaneous presence of
other VRE-colonised patients, and repeated and
prolonged antibiotic treatment, enhanced the risk
of VRE transmission.
The central role of the ICU in the ampliﬁcation
of an endemic problem in the hospital is clear
from this report. VRE-colonised patients were
admitted from several departments of the same
hospital and even from the community, but a
relatively high proportion of patients became
colonised within the ICU, and most were then
discharged as VRE carriers to other departments,
hospitals and outpatient facilities.
The present study used the automated Ribo-
Printer to identify and type the isolates. Although
ribotyping has been shown to be less discrimin-
atory than PFGE for typing E. faecium [24,25], the
method is easy to perform, highly reproducible,
and provides results rapidly to clinicians. Price
et al. [25] considered that this technique was not
useful for epidemiological investigations of VRE,
but Brisse et al. [16] suggested that it could be the
method of choice to determine rapidly whether
isolates were related (e.g., in the case of a hospital
outbreak). In the present study, automated ribo-
typing identiﬁed two distinct E. faecium clones
(thus, it was not too discriminatory); furthermore,
all the isolates appeared, at least during the ﬁrst
period of the study, to be related epidemiologi-
cally. A combination of enzymes (EcoRI + BamHI)
yielded results that were in agreement with those
obtained using only EcoRI. Preliminary results
from other workers have indicated that double
restriction enzyme digestion (AseI + BamHI) has
good discrimination for typing VRE compared
with PFGE (101st General Meeting of the Ameri-
can Society for Microbiology, abstract C-83).
However, enzymes such as AseI are very expen-
sive. Even if automated ribotyping has a lower
discriminatory power compared with other tech-
niques, its advantages (ease of use, speed, stan-
dardisation, availability of public databases, and
high degree of inter-laboratory reproducibility)
mean that it is a very useful rapid screening
method for investigating a hospital outbreak [16].
Two E. faecium isolates, representative of the
two ribotypes containing this species, belonged to
MLST ST78 and ST18, forming part of the genetic
lineage C1. This lineage includes isolates from
hospitalised patients from a wide area of northern
Italy [19]. These two clones were similar to those
obtained in previous studies, as they were deﬁned
by the purK1 allele, described by Homan et al. [18]
as being present in isolates from hospital out-
breaks [19,22]. In particular, ST78 was described
by Stampone et al. [22] as having a wide circula-
tion in Italy. The ST18 isolate was representative
of only two isolates that did not harbour the esp
gene [20]. Even with the limitations of the present
study, these esp-negative isolates showed a very
limited transmission in the ICU.
The most important feature resulting from the
present study was the demonstration of the
predominant role of transmission throughout
the hospital compared with selection, as almost
all isolates belonged to the same ribotype. Anti-
biotic-driven selection may have occurred in two
patients who acquired different VRE strains while
in the ICU, and then transmitted these strains to
one other patient each. The key factor in limiting
VRE epidemics, and in avoiding infection, is
therefore the implementation of measures aimed
at preventing patient-to-patient transmission
[26,27].
As a relatively new pathogen, VRE acts as a
sensitive marker for measuring the effectiveness
of infection control programmes and the appro-
priate application of preventive measures [28,29].
In the present study, all measures recommended
in international guidelines [28] were discussed
during staff meetings and with the infection
control committee; the international recommen-
dations were adapted to local conditions and
implementation was monitored by the infection
control committee. The ICU outbreak was con-
trolled by limiting transmission, but long-term
follow-up surveillance of rectal VRE colonisation
detected occasional importation of colonised
patients from other wards, following dissemin-
ation of VRE throughout the hospital, but no
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further spread among patients in the ICU. Chan-
ges in infection control procedures, together with
the opening of a new unit with an improved
design structure and better hand-washing facilit-
ies, produced a long-lasting positive effect.
The low pathogenicity of VRE (only two VRE
infections among 56 colonised patients) and the
availability of effective antibiotics raise the ques-
tion of whether it is worthwhile and cost-effective
to have a speciﬁc VRE surveillance programme
[30]. It is clear that a VRE surveillance programme
can reduce VRE transmission and selection, and
also verify the efﬁcacy of interventions (which
were clearly far from optimal in this unit)
designed to prevent transmission of other micro-
organisms. VRE is particularly suitable as an Alert
organism for intra-hospital transmission because
it is extremely rare in the healthy population.
Although interruption of transmission in the ICU
should be given the highest priority, implemen-
tation requires adequate structures, sufﬁcient
trained staff, adherence to nursing and cleaning
protocols, and possibly some minimal surveil-
lance to monitor the efﬁcacy of prevention and to
identify any new outbreak as early as possible.
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